The NCCN and ESMO guidelines recommend SIR-Spheres® Y-90 resin microspheres for treatment of chemotherapy refractory or intolerant mCRC.

NCCN v4. 2018 Clinical Practice Guidelines

SIR-Spheres Y90 resin microspheres are recommended for colon and rectal cancer, as an option in highly selected patients with chemo-refractory/ resistant disease and with predominant hepatic metastases.1

ESMO 2016 consensus guideline

SIR-Spheres Y90 resin microspheres are recommended.2

  • for mCRC patients with liver-limited disease failing the available chemotherapeutic options
  • as ‘consolidation treatment’ in earlier treatment lines (limited to clinical trials)

It may also currently be a good alternative in patients who are potential candidates for resection, but display a small future liver remnant (FLR) volume.2

The evidence for the ESMO recommendation on radioembolization is based on clinical studies using SIR-Spheres Y-90 resin microspheres.3

1. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.    Colon Cancer Version 1, 2017
2. Van Cutsem E et al.  Annals of Oncology 2016; 27: 1386–1422.
3. Garlipp B et al. Hepatology 2014; 59:1864-1873.
4. Hendlisz A et al J Clin Oncol 2010; 28:3687-3694.

Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.